Faculty, Staff, and researchers
Our People
Featured researcher
Michael Rafii, MD, PhD
Professor of Clinical Neurology at the Keck School of Medicine and Medical Director of the Alzheimer’s Therapeutic Research Institute (ATRI)
Physician-scientist whose research focuses on developing treatments for Alzheimer’s disease (AD) including a genetic form that occurs in people with Down syndrome (DS)
Director of the Medical Safety Unit of the Alzheimer’s Clinical Trials Consortium (ACTC) and co-director of the Clinical core of the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Featured researcher
Cecily Jenkins, PhD
Recently Published Works
Safety, Efficacy, and Feasibility of Intranasal insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial JAMA Neurol. 2020 Sep 1;77(9):1099-1109
Recognitions
Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research Alzheimers Res Ther. 2020 Jun 30;12(1):78. doi: 10.1186/s13195-020-00643-0
Panels & Presentations
Identification of Alzheimer disease risk by functional magnetic resonance imaging Arch Neurol. 2005 Dec;62(12):1881-8. doi: 10.1001/archneur.62.12.1881.
